Endocrinology

Top Story

Obesity and total joint arthroplasty: Time to examine needs in a different light

Obesity and total joint arthroplasty: Time to examine needs in a different light
Orthopedics Today, February 2016
Ibrahim Azboy, MD; Javad Parvizi, MD, FRCS

The prevalence of obesity in the general population is increasing. Obesity is estimated to affect approximately one-third of adults in the United States. It is estimated that 6.1 million patients who undergo total joint arthroplasty will be obese by 2040.

It is a known fact that obese patients undergoing total joint arthroplasty (TJA) are at higher risk of all complications in general, particularly infection. An increased risk for wound healing, infection, anemia, acute renal insufficiency, respiratory failure and urinary tract infection have been linked to obesity in patients undergoing TJA. Multiple studies have shown obesity can negatively impact the technical performance of both total hip arthroplasty (THA) and total knee arthroplasty (TKA), as well as influence the implant survivorship.

In the Journals

PCOS increases pregnancy complications

February 10, 2016
Women with polycystic ovary syndrome have lower than normal fertility, but rates can be restored after diagnosis, study findings show.According to the researchers…
In the Journals

‘Mini-dose’ glucagon viable option for hypoglycemia in type 1 diabetes

February 10, 2016
Treatment with a “mini-dose” of ready-to-use, subcutaneous glucagon is an effective, alternative treatment for hypoglycemia in adults with type 1 diabetes…
In the Journals

Victoza reduces BMI, other variables in NASH

February 10, 2016
Researchers found that Victoza successfully reduced BMI, cholesterol-low density lipoprotein and other clinical variables in patients with nonalcoholic steatohepatitis…
Meeting News Coverage

Reduced deep sleep tied to poor glycemic control in children with type 1 diabetes

February 10, 2016
Children and adolescents with type 1 diabetes have a significantly reduced percentage of efficient and deep sleep time vs. healthy controls, leading to poor glycemic…
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Meeting News CoverageVideo

VIDEO: Weight loss tips from the Experts — Is it better to be thin or healthy?

December 2, 2015
More »
Featured
CMECNECPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan